Supernus Pharmaceuticals (SUPN) Kev ntsuas ntawv
Supernus Pharmaceuticals
AI kev txhais lus: SUPN
AI tshaj tawm tus nqi hom phiaj rau hnub lag luam tom ntej, kawg lub lis thiab kawg hli. Kev hloov kho raug ntsuas los ntawm tus nqi tshiab. Cov no yog kev ntsuas xav tau, tsis yog kev pab cuam lag luam.
Nqi hauv 6 hli dhau los
Premium qhia AI lub hom phiaj nqi rau 1 hnub, 1 lim tiam thiab 1 hli rau tus no thiab txhua tus stock lwm tus.
Qhib Premium🔒 Kev ntsuas kev txav chav
Kev ntsuas kev txav chav — txhua kev ntsuas dhau los nyob ze rau qhov kawg tiag tiag — yog ib feem ntawm Premium.
Qhib PremiumTxog lub tuam txhab no
Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and delivers patented medicines for the treatment of central nervous system disorders and diseases, including clinical-stage candidates for neurological and psychiatric conditions such as epilepsy, conductive disorder, Parkinson’s disease, ADHD and depression.
